Sunteți pe pagina 1din 18

Norel

Animal Nutrition feeding life


Norel
Miguel Colilla Commercial Director APAC Penang, Aug 17

1 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUT HEALTH_FEED ADDITIVES PATHOGENS CONTROL
_

GUSTOR NRGY

2 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Efficacy of protected sodium butyrate against
Salmonella in broilers (Adapted from Puyalto et al., 2016)
Puyalto2016
M. Puyalto1, C. Sol1, P. Honrubia1, Y. Prez2, R. Balaa-Fouce2, M.J. Villamide3 and J.J. Mallo1

1 NOREL S.A., Madrid, Spain.


1 NOREL S.A
2 Dpt. Ciencias Biomdicas. Universidad de Len, Len, Spain.
2
3 Dpt. Produccin Agraria. Universidad Politcnica de Madrid, Madrid, Spain
3

3 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Efficacy of protected sodium butyrate against
Salmonella in broilers (Adapted from Puyalto et al., 2016)
Puyalto2016
Objective:
A trial was conducted to evaluate the preventive effect of GUSTOR NRGY against
S. Enteritidis infection in broilers, on fecal shedding and in organs content.
GUSTOR N'RGY,

Material and Methods:


Animals: 80 Cobb 1-day-old males broiler chickens. The study lasted 42 d
80Cobb 1 42
1) Treatments
No additive addition
Gustor NRGY (1.3 kg/t of feed) Gustor N'RGY1.3/

Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Efficacy of protected sodium butyrate against
Salmonella in broilers (Adapted from Puyalto et al., 2016)
Puyalto2016
2) Measurements
Presence of Salmonella in feces with cloacal swabs and microbial counts in organs of a 40% of
birds in each treatment (crop, ceca, liver and spleen)
40

5 d Challenge 5

Sampling
1 d 6 d 12d 19 d 26 d 33 d 41 d days

Euthanasia

20% Birds inoculated with 106
CFU S. Enterica CECT 4156
Organs
20106 CFU S. sampling
Enterica CECT 4156

5 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Results: Presence of Salmonella in feces

% of positive animals to Salmonella in cloacal swabs

Positive animals (%) (%)
100
*
80 *
*
60
*
40 *
20

0
6d 12d 19d 26d 33d 41d

Control Gustor N'RGY


* Differences between treatment and Control (P<0.05)
* P <0.05
6 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Results: Presence of Salmonella in organs

% of organs affected by Salmonella

Organs affected (%)
100
a a
a
80

60
b
40
b
20
b
0
Ceca Crop Spleen Liver

Control Gustor N'RGY

7 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
GUSTOR NRGY
Conclusions

It can be concluded that GUSTOR NRGY reduces the


presence of Salmonella in feces and is able to prevent
systemic infection in broilers experimentally challenged
with Salmonella Enteritidis.

GUSTOR N'RGY

8 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
(GUSTOR BP70)(NATESSE)

1Babolna Hybrid


25

Gholiamiandehkordy

(10)
1.

16 18192021 3-6 x 105


CFU 19 10
9 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
371014172023

25 Gholamiandehkordi
et al. (2007)0= 1=2= (1-2cm) ; 3=
(3-4cm)4=

10 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es

NATESSE ()
17
p<0.05)
25


NATESSE

(p<0.07)
(Table 4)

17 23

11 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
Sodium salt of coconut
fatty acid distillate

FA composition
Min 67% crude fat 60

67
50

40
Lauric

30 Capric
Caprilic
20 Others

10

0
Coconut oil

12 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
In vitro Trials
Morphological changes in C.
perfringens after 30 min incubation of
cells with lauric acid at 1 mg /ml.
1/
30

Although there was no visible Normal


alteration in the cell wall structure and
size of cells, the separation of inner
and outer membranes and complete
cytoplasm disorganization in lauric
acid-treated cells are apparent



Cytoplasm disorganization

Skrivanova et al., 2005
13 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
In vitro Trials: MIC and MBC
MIC: Minimal inhibitory concentration of a product that inhibits the
growth of a microorganism (bacteriostatic activity)

MBC: Lowest concentration of a product with antimicrobial activity


able to kill the 99.9% of microorganisms (bactericide)

2400 ppm
1200 ppm
No growth
600 ppm
MIC: No visible growth
300 ppm

150 ppm
Growth 75 ppm

Positive Control

Negative Control

Product X
1, 2, 3 replicates
CDTI MIMBIOPOR, 2016
14 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
In vitro Trials: MIC and MBC
MIC: Minimal inhibitory concentration of a product that
inhibits the growth of a microorganism (bacteriostatic activity)

MBC: Lowest concentration of a product with antimicrobial


activity able to kill the 99.9% of microorganisms (bactericide)
99.9
Product X (300 ppm)
1, 2, 3 replicates
Growth

No growth

Product X (600 ppm) MBC: No colonies of


1, 2, 3 replicates microorganisms

CDTI MIMBIOPOR, 2016


15 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
In vitro Trials: Material and Methods

Strains evaluated
Cl. Perfringens
E. Coli Salmonella

Identification Haemolysis Identification Serotype Identification

Cholerasuis
CECT 434 + CECT 915 CP 3

EC 58 + CECT 4300 Enteriditis CP 34

EC 59 + CECT 700 Infantis CP 52


Typhimurium
EC 60 + CECT 443 CP 89

Typhimurium
EC 61 + CECT 883 CP 99

Typhimurium
EC 67 + SP 11 CP H

EC 96 + SP 28 London

EC 107 +
CDTI MIMBIOPOR, 2016
16 EC 115 + Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
In vitro Trials: MIC and MBC

RESULTS: MIC (ppm) PPM
E. Coli Salmonella Cl. Perfringens
Product

pH 4.8 pH 6 pH 4.8 pH 6 pH 4.8 pH 6
B98 512 50000 256 125000 nd2 31250
Dicosan 1024 > 50001 256 > 50001 nd2 7.68
RESULTS: MBC (ppm) PPM
E. Coli Salmonella Cl. Perfringens
Product

pH 4.8 pH 6 pH 4.8 pH 6 pH 4.8 pH 6
B98 62500 62500 125000 125000 nd2 62500
Dicosan >50001 >50001 256 >50001 nd2 7.68
1 It was not possible to start at higher concentration
At low pH, bacteria are more sensible to the products tested
2 Cl. Perfringens did not grow at ph 4.8
pH
DICOSAN had higher bacteriostatic and bactericide effect against Cl. Perfringens
DICOSAN CDTI MIMBIOPOR, 2016
17 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es
THANK YOU VERY MUCH FOR
YOUR ATTENTION

18 Norel, S.A. CIF: A-28617801 C/Jess Aprendiz, 19 1 A y B, 28007 Madrid SPAIN +34 915 014 041 www.norel.es norel@norel.es

S-ar putea să vă placă și